The Cigna Group is a global health company that operates the Evernorth Health Services and Cigna Healthcare segments, and the question for the next twelve months is whether the company can convert the 7% Q2 2026 revenue growth, the $2.1 billion adjusted income from operations, the 6% adjusted income from operations growth, and the raised 2026 outlook into the kind of diversified-health-services operating leverage the company has been telegraphing. The Q2 2026 print was the cleanest test of that thesis, and the cleanest signal is that the company raised its 2026 outlook for adjusted income from operations to at least $30.45 per share on the back of "solid operational performance across its diversified portfolio of businesses." The strategic tension is the 3% decline in total customer relationships versus the 7% revenue growth, and the forward question is whether the Evernorth Health Services segment can keep delivering the operating leverage and whether the Cigna Healthcare segment can grow the medical customer base.
The 7% revenue growth was led by both segments, and the operating leverage was clean. The Q2 2026 total revenues grew to $71.7 billion, driven by growth in both Evernorth Health Services and Cigna Healthcare. The Q2 2026 adjusted income from operations of $2.1 billion, or $7.78 per share, was up 6% year over year. The Q2 2026 shareholders net income of $1.7 billion, or $6.29 per share, was primarily reflecting growth in Cigna Healthcare.
The 4.8% Q2 2026 SG&A expense ratio and the 4.6% Q2 2026 adjusted SG&A expense ratio, both below the prior-year quarter's 5.1% and 4.9%, are the cleanest single read on the operating efficiency. The 0.9 million shares repurchased for approximately $250 million year to date through July 29, 2026 anchor the capital return. The forward question is whether the Evernorth Health Services segment can keep delivering the operating leverage, and whether the Cigna Healthcare segment can grow the medical customer base.